Hypoglycemia in type 1 diabetes.
作者信息
McCrimmon Rory J, Sherwin Robert S
机构信息
Biomedical Research Institute, University of Dundee, Dundee, Scotland.
出版信息
Diabetes. 2010 Oct;59(10):2333-9. doi: 10.2337/db10-0103.
Abstract
摘要
相似文献
1
Hypoglycemia in type 1 diabetes.
Diabetes. 2010 Oct;59(10):2333-9. doi: 10.2337/db10-0103.
2
[Hypoglycemia--simply annoying or dangerous?].
MMW Fortschr Med. 2016 Jun 9;158(11):67-70. doi: 10.1007/s15006-016-8385-8.
3
Hypoglycemia: New Definitions and Regulatory Implications.
Diabetes Technol Ther. 2018 Jun;20(S2):S250-S253. doi: 10.1089/dia.2018.0113. Epub 2018 Jun 6.
4
Elimination of hypoglycemia from the lives of people affected by diabetes.
Diabetes. 2011 Jan;60(1):24-7. doi: 10.2337/db10-1359.
5
Severe hypoglycaemia the "tip of the iceberg": an underestimated risk in both type 1 and type 2 diabetic patients.
Diabetes Metab. 2015 Apr;41(2):105-6. doi: 10.1016/j.diabet.2015.01.005. Epub 2015 Mar 29.
6
[Emergencies in general practice, 12. Hypoglycemic crisis].
MMW Fortschr Med. 2001 Apr 26;143(17):39-40.
7
ISPAD Clinical Practice Consensus Guidelines 2014. Assessment and management of hypoglycemia in children and adolescents with diabetes.
Pediatr Diabetes. 2014 Sep;15 Suppl 20:180-92. doi: 10.1111/pedi.12174. Epub 2014 Jul 12.
8
Insulin therapy and hypoglycemia.
Endocrinol Metab Clin North Am. 2012 Mar;41(1):57-87. doi: 10.1016/j.ecl.2012.03.001. Epub 2012 Apr 17.
9
[Different strategies in prediabetes, new and long-time diabetes. What therapy for what diabetics?].
MMW Fortschr Med. 2010 Jan 21;152(3):12-4, 16. doi: 10.1007/BF03365914.
10
Prevention of hypoglycemia while achieving good glycemic control in type 1 diabetes: the role of insulin analogs.
Diabetes Care. 2008 Feb;31 Suppl 2:S113-20. doi: 10.2337/dc08-s227.
引用本文的文献
1
Continuous Glucose Monitoring in Patients With Postbariatric Hypoglycemia: Effect on Hypoglycemia and Quality of Life.
J Endocr Soc. 2025 Jun 18;9(9):bvaf106. doi: 10.1210/jendso/bvaf106. eCollection 2025 Sep.
2
Incorporating Uncertainty Estimation and Interpretability in Personalized Glucose Prediction Using the Temporal Fusion Transformer.
Sensors (Basel). 2025 Jul 26;25(15):4647. doi: 10.3390/s25154647.
3
An AI-based module for interstitial glucose forecasting enabling a "Do-It-Yourself" application for people with type 1 diabetes.
Front Digit Health. 2025 Jun 13;7:1534830. doi: 10.3389/fdgth.2025.1534830. eCollection 2025.
4
Recurrent education: A promising strategy for enhancing diabetes management and reducing hypoglycemia in children with type 1 diabetes.
BMC Endocr Disord. 2025 Apr 21;25(1):109. doi: 10.1186/s12902-025-01917-0.
5
Activation of the Nrf2 Pathway by Sulforaphane Improves Hypoglycaemia-Induced Cognitive Impairment in a Rodent Model of Type 1 Diabetes.
Antioxidants (Basel). 2025 Mar 4;14(3):308. doi: 10.3390/antiox14030308.
6
Parent Feedback on the Reducing Emotional Distress for Childhood Hypoglycemia in Parents (REDCHiP) Intervention: A Qualitative Analysis.
Children (Basel). 2025 Mar 14;12(3):360. doi: 10.3390/children12030360.
7
The effects of empagliflozin in patients with type 1 diabetes: Results of a 12-week, double-blind, randomized, placebo-controlled clinical trial.
Health Promot Perspect. 2024 Dec 30;14(4):380-387. doi: 10.34172/hpp.42486. eCollection 2024.
8
Glucagon-like peptide-1 receptor agonists and type 1 diabetes: a potential game changer?
Front Endocrinol (Lausanne). 2025 Jan 21;15:1520313. doi: 10.3389/fendo.2024.1520313. eCollection 2024.
9
Metabolic interventions as adjunctive therapies to insulin in type 1 diabetes: Current clinical landscape and perspectives.
Diabetes Obes Metab. 2025 Mar;27(3):1032-1044. doi: 10.1111/dom.16154. Epub 2025 Jan 6.
10
Determinants of Liraglutide Treatment Discontinuation in Type 1 Diabetes: A Post Hoc Analysis of ADJUNCT ONE and ADJUNCT TWO Randomized Placebo-Controlled Clinical Studies.
J Diabetes Sci Technol. 2025 Mar;19(2):321-331. doi: 10.1177/19322968241305647. Epub 2024 Dec 24.
本文引用的文献
1
Influence of insulin in the ventromedial hypothalamus on pancreatic glucagon secretion in vivo.
Diabetes. 2010 Jun;59(6):1521-7. doi: 10.2337/db10-0014. Epub 2010 Mar 18.
2
Ablation of AMP-activated protein kinase alpha1 and alpha2 from mouse pancreatic beta cells and RIP2.Cre neurons suppresses insulin release in vivo.
Diabetologia. 2010 May;53(5):924-36. doi: 10.1007/s00125-010-1692-1. Epub 2010 Mar 11.
3
Ventromedial hypothalamic nitric oxide production is necessary for hypoglycemia detection and counterregulation.
Diabetes. 2010 Feb;59(2):519-28. doi: 10.2337/db09-0421. Epub 2009 Nov 23.
4
Sweet talk in the brain: glucosensing, neural networks, and hypoglycemic counterregulation.
Front Neuroendocrinol. 2010 Jan;31(1):32-43. doi: 10.1016/j.yfrne.2009.10.006. Epub 2009 Oct 24.
5
Measurement of cerebral oxidative glucose consumption in patients with type 1 diabetes mellitus and hypoglycemia unawareness using (13)C nuclear magnetic resonance spectroscopy.
Metabolism. 2010 Jan;59(1):100-6. doi: 10.1016/j.metabol.2009.07.012. Epub 2009 Sep 18.
6
Hypoglycemia: from the laboratory to the clinic.
Diabetes Care. 2009 Aug;32(8):1364-71. doi: 10.2337/dc09-0113.
7
Effects of the selective serotonin reuptake inhibitor fluoxetine on counterregulatory responses to hypoglycemia in individuals with type 1 diabetes.
Diabetes. 2008 Dec;57(12):3315-22. doi: 10.2337/db08-1000. Epub 2008 Oct 3.
8
Bringing light to the dark side of insulin: a journey across the blood-brain barrier.
Diabetes. 2008 Sep;57(9):2259-68. doi: 10.2337/db08-9023.
9
Increased GABAergic tone in the ventromedial hypothalamus contributes to suppression of counterregulatory responses after antecedent hypoglycemia.
Diabetes. 2008 May;57(5):1363-70. doi: 10.2337/db07-1559. Epub 2008 Mar 28.
10
The selective serotonin reuptake inhibitor sertraline enhances counterregulatory responses to hypoglycemia.
Am J Physiol Endocrinol Metab. 2008 May;294(5):E853-60. doi: 10.1152/ajpendo.00772.2007. Epub 2008 Mar 11.
Zotero 插件